Desai, MBBS, MD, assistant professor of thoracic medical oncology/head and neck medical oncology at Fox Chase Cancer Center ...

TP53 alterations independently predicted inferior remission, EFS, and OS after CAR T-cell therapy in relapsed/refractory B-ALL.

Activation of a specific part of the Dicer enzyme can change its shape in a way that affects its critical role in proper cell ...

HOUSTON, APRIL 28, 2026 ― Activation of a specific part of the Dicer enzyme can change its shape in a way that affects its critical role in proper ...

Michele Carbone and Haining Yang, professors at University of Hawaiʻi Cancer Center, are recipients of the prestigious V ...

Recent advances in genetic testing, artificial intelligence, and cellular biology are transforming liver disease diagnosis, prevention, and treatment. Studies highlight how genomic insights, AI-driven ...

In a prospective validation study, researchers at The University of Texas MD Anderson Cancer Center have demonstrated that a ...

HOUSTON, APRIL 23, 2026 ― In a prospective validation study, researchers at The University of Texas MD Anderson Cancer Center demonstrated that a ...

A round-up of some of the latest advances in cancer reseacher presented by MSK scientists at the 2026 American Association ...

A large-scale genomic study published February 19 in Science has produced the first comprehensive map of the feline oncogenome, identifying key similarities between cancer-driving mutations in cats ...

It’s well established that some cases of amyotrophic lateral sclerosis (ALS) are caused by mutations that are inherited from a person’s parents — but a new study shows some cases of sporadic ALS may ...

Illumina Inc. (NASDAQ: ILMN) today announced the launch of DRAGEN™ version 4.5 software (v4.5), one of the most substantial expansions of the software's capabilities to date. As genomic researchers ...